M. Osborne

Midbrain‐renal dopaminergic axis and control of venous capacitance: Pathological and therapeutic significance in hypertension

M. Osborne, F. Kovzelove, 1982 .

The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.

M. Osborne, J. Wenger, W. Willems, 1971, The Journal of pharmacology and experimental therapeutics.

Effects of Reserpine on Urinary Bladder Tension

M. Osborne, R. Maxwell, A. Plummer, 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

QUINDONIUM BROMIDE--SOME ASPECTS OF THE CARDIOVASCULAR PHARMACOLOGY.

M. Osborne, M. Winbury, 1965, The Journal of pharmacology and experimental therapeutics.

The influence of volume loading on the inotropic effect of Ro 7-2956.

M. Osborne, J. Wenger, R. J. Barrett, 1974, European journal of pharmacology.

The cardiovascular pharmacology of methyldopa using graphic segmental circulatory analysis.

M. Osborne, J. Wenger, R. J. Barrett, 1974, Journal of Pharmacology and Experimental Therapeutics.

The cardiovascular pharmacology of the antibiotic ionophore Ro 2-2985 (X537A).

M. Osborne, J. Wenger, M. Zanko, 1977, The Journal of pharmacology and experimental therapeutics.